Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSB2300044	注射用BD0801	sevacizumab	Lyophilized	Biological Products(1)	Supplementary Application	2023-04-25		Shanghai Xianxiang Pharmaceutical Technology Co Ltd			view
CXSL2101100	注射用BD0801	sevacizumab	Lyophilized	Biological Products(1)	New Drug Application	2021-05-31		Jiangsu Simcere Pharmaceutical Co Ltd			view
CXSB2100015	注射用BD0801	sevacizumab	Lyophilized	Biological Products(1)	Supplementary Application	2021-03-10	江苏先声药业有限公司	Jiangsu Simcere Pharmaceutical Co Ltd	In Review	2021-03-09	view
CXSL2000336	注射用BD0801	sevacizumab	Lyophilized	Biological Products(1)	New Drug Application	2020-12-03	江苏先声药业有限公司	Jiangsu Simcere Pharmaceutical Co Ltd	In Review	2020-12-02	view